Hancock Jaffe Laboratories Stock Price

0.0843 (26.02%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Hancock Jaffe Laboratories Inc HJLI NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Previous Close Last Traded
0.0843 26.02% 0.4083 0.312 0.45 0.3256 0.324 19:59:17
Bid Price Ask Price Spread Spread % News
0.4065 0.4083 0.0018 0.44% 1 -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
13,050 15,824,441 $ 0.3841443 $ 6,078,869 2,630,618 0.2111 - 1.20
Last Trade Time Type Quantity Stock Price Currency
19:59:16 formt 103 $ 0.4083 USD

Hancock Jaffe Laboratories Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 15.44M 38.32M 33.02M $ 31.24k $ - -0.49 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Hancock Jaffe Laboratories News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical HJLI Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.32640.4840.3120.32588331,944,1220.081925.09%
1 Month0.39520.4840.290.34831613,235,4110.01313.31%
3 Months0.38940.640.290.37760142,155,9670.01894.85%
6 Months0.580.780.21110.37977961,062,514-0.1717-29.6%
1 Year1.061.200.21110.3963304558,334-0.6517-61.48%
3 Years5.005.640.21110.7926834334,172-4.59-91.83%
5 Years5.005.640.21110.7926834334,172-4.59-91.83%

Hancock Jaffe Laboratories Description

Hancock Jaffe Laboratories Inc is a medical device company. It develops and sells biological tissue solutions to treat patients with coronary, vascular, end-stage renal and peripheral arterial diseases in the United States and Europe. The company develops and manufactures implantable cardiovascular bioprosthetic devices. Its key products include Bioprosthetic Heart Valve, CoreoGraft- Bypass Graft, and the Venous Valve.

Your Recent History
Hancock Ja..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.